Research Paper Volume 15, Issue 20 pp 11588—11610

Immunobiological signatures and the emerging role of SPP1 in predicting tumor heterogeneity, malignancy, and clinical outcomes in stomach adenocarcinoma

class="figure-viewer-img"

Figure 9. Immunotherapy analysis. (A, B) Gene expression of immune checkpoint molecules and pyroptosis-related genes in high- and low-risk groups. (C) GSVA analysis telling which functions or pathways were active in high- and low-risk groups with * indicated correlation, green indicated negative correlation, and red indicated positive correlation. (DG) Immunotherapy analysis to compare the effect of immunotherapy in high- and low-risk groups. (HK) Drug sensitivity analysis of various drugs differences between high- and low-risk groups with p-value < 0.05 indicating a difference.